CJC-1295-5MG
CJC-1295 5MG is a synthetic growth hormone–releasing hormone (GHRH) analog investigated in endocrine, metabolic, and laboratory research. CJC-1295 formulations may differ depending on whether a drug-affinity complex (DAC) modification is present, so the exact product identity should be confirmed using the product label and batch-specific documentation.
$90.00
Satisfaction Guaranteed
Secure
Payment
Third-party
Tested
CJC-1295 5MG
CJC-1295 5MG is a synthetic growth hormone–releasing hormone (GHRH) analog investigated in endocrine, metabolic, and laboratory research. CJC-1295 formulations may differ depending on whether a drug-affinity complex (DAC) modification is present, so the exact product identity should be confirmed using the product label and batch-specific documentation.
Research Context
Research involving CJC-1295 examines GHRH receptor signaling, endogenous growth hormone secretion, insulin-like growth factor 1 (IGF-1) regulation, and downstream endocrine pathways. Experimental and clinical studies have investigated modified GHRH analogs for their pharmacokinetic properties and prolonged stimulation of growth hormone–related signaling.
Research Overview
Laboratory research involving CJC-1295 may evaluate receptor binding, intracellular signaling, growth hormone release, IGF-1-associated responses, and peptide stability. The presence or absence of DAC can substantially affect pharmacokinetic characteristics and experimental behavior, so findings from one formulation should not automatically be applied to another.
Key Research Focus Areas
- GHRH Receptor Research: Investigation of GHRH receptor binding and downstream signaling pathways.
- Growth Hormone Research: Study of endogenous growth hormone secretion and associated endocrine communication.
- IGF-1 Signaling: Evaluation of IGF-1-associated molecular and metabolic pathways.
- Endocrine Research: Investigation of feedback mechanisms and interactions within the growth hormone axis.
- Peptide Characterization: Evaluation of identity, purity, stability, compatibility, and analytical properties under standardized research protocols.
Important Compliance and Safety Information
CJC-1295 is an investigational research compound and should not be represented as an approved human or veterinary therapeutic. The 5MG designation indicates the quantity supplied and does not by itself establish concentration, formulation, route of administration, or intended use.
For research use only. Not for human or animal consumption.
Lab Report
Research Use Disclaimer
Research Use Only: All products offered are intended strictly for laboratory research purposes. Products are not for human consumption and are not intended for diagnostic, therapeutic, or medical use. By purchasing from our website, customers confirm they are qualified researchers or laboratories and understand the intended research-use designation.
Related Compounds
Related products
-

KPV 10MG
$73.00 -

GHK-CU
$125.00 – $130.00Price range: $125.00 through $130.00This product has multiple variants. The options may be chosen on the product page -

KLOW 80MG
$80.00 -

PT141-10MG
$80.00
